Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/43557
Type
ArticleCopyright
Open access
Collections
- ENSP - Artigos de Periódicos [2411]
- IFF - Artigos de Periódicos [1300]
- INI - Artigos de Periódicos [3646]
- IOC - Artigos de Periódicos [12969]
Metadata
Show full item record
ZIKA VIRUS VERTICAL TRANSMISSION IN CHILDREN WITH CONFIRMED ANTENATAL EXPOSURE
Author
Brasil, Patrícia
Vasconcelos, Zilton Farias Meira de
Kerin, Tara
Gabaglia, Claudia Raja
Ribeiro, Ieda P.
Bonaldo, Myrna C.
Damasceno, Luana
Pone, Marcos V.
Pone, Sheila Moura
Zin, Andrea
Tsui, Irena
Adachi, Kristina
Pereira Jr, Jose Paulo
Gaw, Stephanie L.
Carvalho, Liege
Cunha, Denise C.
Guida, Leticia
Rocha, Mirza
Cherry, James D.
Wang, Lulan
Aliyari, Saba
Cheng, Genhong
Foo, Suan-Sin
Chen, Weiqiang
Jung, Jae
Brickley, Elizabeth
Moreira, Maria Elisabeth L.
Nielsen-Saines, Karin
Vasconcelos, Zilton Farias Meira de
Kerin, Tara
Gabaglia, Claudia Raja
Ribeiro, Ieda P.
Bonaldo, Myrna C.
Damasceno, Luana
Pone, Marcos V.
Pone, Sheila Moura
Zin, Andrea
Tsui, Irena
Adachi, Kristina
Pereira Jr, Jose Paulo
Gaw, Stephanie L.
Carvalho, Liege
Cunha, Denise C.
Guida, Leticia
Rocha, Mirza
Cherry, James D.
Wang, Lulan
Aliyari, Saba
Cheng, Genhong
Foo, Suan-Sin
Chen, Weiqiang
Jung, Jae
Brickley, Elizabeth
Moreira, Maria Elisabeth L.
Nielsen-Saines, Karin
Affilliation
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
David Geffen UCLA School of Medicine. Los Angeles, CA, USA.
Biomedical Research Institute of Southern California. Oceanside, CA, USA.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
David Geffen UCLA School of Medicine. Los Angeles, CA, USA.
David Geffen UCLA School of Medicine. Los Angeles, CA, USA.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
University of California. San Francisco School of Medicine. San Francisco, CA, USA.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sérgio Arouca. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
David Geffen UCLA School of Medicine. Los Angeles, CA, USA.
David Geffen UCLA School of Medicine. Los Angeles, CA, USA.
David Geffen UCLA School of Medicine. Los Angeles, CA, USA.
David Geffen UCLA School of Medicine. Los Angeles, CA, USA.
University of Southern California. Los Angeles, CA, USA.
University of Southern California. Los Angeles, CA, USA.
University of Southern California. Los Angeles, CA, USA.
London School of Hygiene and Tropical Medicine. Department of Infectious Disease Epidemiology. London, UK.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
David Geffen UCLA School of Medicine. Los Angeles, CA, USA.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
David Geffen UCLA School of Medicine. Los Angeles, CA, USA.
Biomedical Research Institute of Southern California. Oceanside, CA, USA.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
David Geffen UCLA School of Medicine. Los Angeles, CA, USA.
David Geffen UCLA School of Medicine. Los Angeles, CA, USA.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
University of California. San Francisco School of Medicine. San Francisco, CA, USA.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sérgio Arouca. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
David Geffen UCLA School of Medicine. Los Angeles, CA, USA.
David Geffen UCLA School of Medicine. Los Angeles, CA, USA.
David Geffen UCLA School of Medicine. Los Angeles, CA, USA.
David Geffen UCLA School of Medicine. Los Angeles, CA, USA.
University of Southern California. Los Angeles, CA, USA.
University of Southern California. Los Angeles, CA, USA.
University of Southern California. Los Angeles, CA, USA.
London School of Hygiene and Tropical Medicine. Department of Infectious Disease Epidemiology. London, UK.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
David Geffen UCLA School of Medicine. Los Angeles, CA, USA.
Abstract
We report Zika virus (ZIKV) vertical transmission in 130 infants born to PCR+ mothers at the time of the Rio de Janeiro epidemic of 2015-2016. Serum and urine collected from birth through the first year of life were tested by quantitative reverse transcriptase polymerase chain reaction (PCR) and/or IgM Zika MAC-ELISA. Four hundred and seven specimens are evaluated; 161 sera tested by PCR and IgM assays, 85 urines by PCR. Sixty-five percent of children (N = 84) are positive in at least one assay. Of 94 children tested within 3 months of age, 70% are positive. Positivity declines to 33% after 3 months. Five children are PCR+ beyond 200 days of life. Concordance between IgM and PCR results is 52%, sensitivity 65%, specificity 40% (positive PCR results as gold standard). IgM and serum PCR are 61% concordant; serum and urine PCR 55%. Most children (65%) are clinically normal. Equal numbers of children with abnormal findings (29 of 45, 64%) and normal findings (55 of 85, 65%) have positive results, p = 0.98. Earlier maternal trimester of infection is associated with positive results (p = 0.04) but not clinical disease (p = 0.98). ZIKV vertical transmission is frequent but laboratory confirmed infection is not necessarily associated with infant abnormalities.
Share